A Phase III Study of SHR-A1811 in Combination With Chemotherapy and Adebrelimab in Previously Untreated Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

The First Hospital of China Medical University, Shenyang, Liaoning

Zhongshan Hospital，Fudan University, Shanghai, Shanghai Municipality